PreetNama
English News

US father-son duo jailed for helping former Nissan boss Carlos Ghosn flee Japan

A Tokyo court on Monday sentenced US Army Special Forces veteran Michael Taylor for two years, and his son Peter for one year and eight months for aiding former Nissan Motor Co Ltd chairman, Carlos Ghosn flee to Lebanon.

“This case enabled Ghosn, a defendant of serious crime, to escape overseas,” Hideo Nirei, the chief judge, said while explaining the judgement. “One year and a half has passed, but there is no prospect of the trial being held.”

The two men, who had faced up to three years in prison, pleaded guilty and made a tearful apology to the court last month, saying they regretted their role in smuggling Ghosn out of Japan hidden in a box aboard a private jet from the Kansai airport at the end of 2019.

Prosecutors said the Taylors received $1.3 million for their services and another $500,000 for legal fees.

Ghosn remains a fugitive in his childhood home of Lebanon, which doesn’t have an extradition treaty with Japan.

In Japan, he faces charges he understated his compensation in Nissan’s financial statements by 9.3 billion yen ($85 million) over a decade and enriched himself at his employer’s expense through payments to car dealerships in the Middle East.

Greg Kelly, a former Nissan executive charged with helping Ghosn hide his compensation, is also on trial in Tokyo. Both Ghosn and Kelly deny the charges.

Related posts

he plans for AstraZeneca’s new headquarters and large R&D campus in Cambridge were unveiled in 2013, but its costs and timeframe have exceeded the initial estimate of 330 million pounds and an aimed completion date of 2016. AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialised medicines and next-generation therapeutics, including gene-editing and cell therapies. “We will have advances that could come to the clinic in the next three, four years, that can lead to really effective new drugs in various aspects of treating cancer,” Dr Susan Galbraith, AstraZeneca’s executive vice president, Oncology Research & Development, told Reuters in an interview. “I’m very optimistic about the fact that we can make a big difference to this disease in the coming decade”.

On Punjab

Pak women journalists accuse Imran Khan’s govt of instigating online abuse

On Punjab

Joining the poll dots in Kashmir: J&K Assembly Elections 10 years after the last Assembly elections were conducted in J&K, then a state, the UT is set to witness a keen contest in the 3-phase polls | For all the noise about the new players, it’s the traditional parties that are set to dominate

On Punjab